JosephCharlesTorkildsonMDMBA
Pediatric Hematology & Oncology • Mesa, AZPediatric Neuro-Oncology
Lead Physician, Hematology/Oncology
Dr. Torkildson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1432 S Dobson Rd
Ste 107
Mesa, AZ 85202Phone+1 480-412-4100Fax+1 480-412-5154
Summary
- Joseph Torkildson, MD, is a healthcare provider based in Mesa, AZ, specializing in Pediatric Hematology & Oncology with a subspecialty in Pediatric Neuro-Oncology. He gained his education at Children's Hospital Los Angeles, US Naval Hospital, Medical College of Wisconsin, and also holds an MBA from the University of Texas. Dr. Torkildson has expertise in areas such as bone marrow transplantation and pediatric neuro-oncology. His significant contributions to scientific literature include multiple widely cited publications in Acta Neuropathologica and The Lancet. Additionally, he has been involved in several clinical trials focusing on progressive low-grade gliomas in children, new treatments for BRAFV600E-mutant gliomas, and testing the psychological effects of cancer in younger patients.
Education & Training
University of Texas at San AntonioMBA, Business, 2001 - 2003
Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 1990- US Naval Hospital1985
- US Naval Hospital1982 - 1983
Medical College of WisconsinClass of 1982
Certifications & Licensure
AZ State Medical License 2019 - 2025
CA State Medical License 2003 - 2021
NV State Medical License 2004 - 2019
VA State Medical License 1993 - 2004- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
- Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Start of enrollment: 2004 Feb 16
- Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
- Join now to see all
Publications & Presentations
PubMed
- 65 citationsIntensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with ce...Wafik Zaky, Girish Dhall, Lingyun Ji, Kelley Haley, Jeffrey C. Allen
Pediatric Blood & Cancer. 2014-01-01 - 52 citationsTargeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.Cassie N Kline, Nancy M Joseph, James P Grenert, Jessica van Ziffle, Eric Talevich
Neuro-Oncology. 2017-05-01 - 49 citationsPrimary intracranial sarcomas with DICER1 mutation often contain prominent eosinophilic cytoplasmic globules and can occur in the setting of neurofibromatosis type 1Julieann C. Lee, Javier Villanueva-Meyer, Sean P. Ferris, Emily A. Sloan, Jeffrey W. Hofmann
Acta Neuropathologica. 2019-01-16
Journal Articles
- The Genetic Landscape of Gliomas Arising After Therapeutic RadiationIwei Yeh, Corey Raffel, Mitchel Berger, Joanna J Phillips, James P Grenert, Boris C Bastian, David A Solomon, Nicholas Butowski, Sabine Mueller, Cassie Kline, Manish A..., Acta Neuropathologica
Press Mentions
Banner Children’s Blood & Cancer Center Opens to Serve the East ValleyAugust 26th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
